A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer C Alves, F Batel-Marques, AF Macedo Diabetes research and clinical practice 98 (2), 271-284, 2012 | 214 | 2012 |
The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer–a systematic review D Mendes, C Alves, N Afonso, F Cardoso, JL Passos-Coelho, L Costa, ... Breast Cancer Research 17, 1-14, 2015 | 206 | 2015 |
Number needed to treat (NNT) in clinical literature: an appraisal D Mendes, C Alves, F Batel-Marques BMC medicine 15, 1-13, 2017 | 150 | 2017 |
Avaliação psicométrica e adaptação cultural e linguística de instrumentos de medição em saúde: princípios metodológicos gerais PL Ferreira, FB Marques Universidade de Coimbra, Centro de Estudos e Investigação em Saúde, 1998 | 112 | 1998 |
Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according … AF Macedo, FB Marques, CF Ribeiro, F Teixeira Journal of clinical pharmacy and therapeutics 28 (2), 137-143, 2003 | 111 | 2003 |
Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis C Alves, D Mendes, FB Marques European journal of clinical pharmacology 75, 1431-1443, 2019 | 104 | 2019 |
Prevalence of undiagnosed hypothyroidism in Europe: a systematic review and meta-analysis D Mendes, C Alves, N Silverio, FB Marques European thyroid journal 8 (3), 130-143, 2019 | 93 | 2019 |
Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel AF Macedo, FB Marques, CF Ribeiro, F Teixeira Pharmacoepidemiology and drug safety 14 (12), 885-890, 2005 | 90 | 2005 |
A systematic review of observational studies evaluating costs of adverse drug reactions F Batel Marques, A Penedones, D Mendes, C Alves ClinicoEconomics and outcomes research, 413-426, 2016 | 79 | 2016 |
Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? AF Macedo, FB Marques, CF Ribeiro Drug safety 29, 697-702, 2006 | 59 | 2006 |
Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports D Mendes, C Alves, F Batel Marques Journal of Nursing Management 22 (3), 322-330, 2014 | 44 | 2014 |
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions AF Macedo, C Alves, N Craveiro, FB Marques Journal of nursing management 19 (3), 395-399, 2011 | 44 | 2011 |
Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis C Alves, F Batel-Marques, AF Macedo Journal of Cardiovascular Pharmacology and Therapeutics 17 (3), 266-276, 2012 | 43 | 2012 |
Data sources on drug safety evaluation: a review of recent published meta‐analyses C Alves, F Batel‐Marques, AF Macedo Pharmacoepidemiology and drug safety 21 (1), 21-33, 2012 | 40 | 2012 |
Sources of information used by regulatory agencies on the generation of drug safety alerts C Alves, AF Macedo, FB Marques European journal of clinical pharmacology 69, 2083-2094, 2013 | 36 | 2013 |
Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events D Mendes, C Alves, F Batel‐Marques Journal of clinical pharmacy and therapeutics 39 (3), 307-313, 2014 | 34 | 2014 |
A systematic review and meta‐analysis of the association between systemic fluoroquinolones and retinal detachment C Alves, A Penedones, D Mendes, F Batel Marques Acta ophthalmologica 94 (5), e251-e259, 2016 | 32 | 2016 |
Desperdício de medicamentos no ambulatório em Portugal Z Mendes, S Crisóstomo, FB Marques, AP Martins, V Rodrigues, ... Revista Portuguesa de Medicina Geral e Familiar 26 (1), 12-20, 2010 | 32 | 2010 |
Interacções medicamentosas como causa de iatrogenia evitável C Monteiro, FB Marques, CF Ribeiro Revista Portuguesa de Medicina Geral e Familiar 23 (1), 63-73, 2007 | 30 | 2007 |
The risk of infections associated with JAK inhibitors in rheumatoid arthritis: a systematic review and network meta-analysis C Alves, A Penedones, D Mendes, FB Marques JCR: Journal of Clinical Rheumatology 28 (2), e407-e414, 2022 | 29 | 2022 |